High Expression of the Receptor Tyrosine Kinase Tie-1 in Acute Myeloid Leukemia and Myelodysplastic Syndrome
- 1 January 2001
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 42 (3) , 511-516
- https://doi.org/10.3109/10428190109064609
Abstract
The tyrosine kinase receptor Tie-1 has been shown to play a role in angiogenesis and hematopoiesis. We evaluated the level of expression and clinical significance of Tie-1 protein in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). We used western blot analysis to confirm and radioimmunoassay to quantify Tie-1 protein expression in bone marrow samples obtained from untreated patients having AML (66 patients) or MDS (29 patients). Samples obtained from these patients contained significantly higher levels of Tie-1 protein than did control samples (p < 0.001). Also, Tie-1 levels were significantly higher in AML patients than MDS patients (p < 0.0001). Tie-1 levels did not correlate with complete remission or survival duration in patients having either disease. These data suggest that Tie-1 expression is increased in AML and MDS but that the level of expression does not influence the response to current therapy. The role of Tie-1 overexpression in the reported increased vascularity in the bone marrow of AML and MDS patients requires further investigation.Keywords
This publication has 14 references indexed in Scilit:
- Angiogenesis in acute and chronic leukemias and myelodysplastic syndromesBlood, 2000
- Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemiaBlood, 2000
- Bone Marrow in Polycythemia Vera, Chronic Myelocytic Leukemia, and Myelofibrosis Has an Increased VascularityThe American Journal of Pathology, 2000
- Increased angiogenesis in the bone marrow of patients with acute myeloid leukemiaBlood, 2000
- Evidence of increased angiogenesis in patients with acute myeloid leukemiaBlood, 2000
- Increased serum levels of vascular endothelial growth factor predict risk of progression in early B‐cell chronic lymphocytic leukaemiaBritish Journal of Haematology, 1999
- Cellular Vascular Endothelial Growth Factor Is a Predictor of Outcome in Patients With Acute Myeloid LeukemiaBlood, 1999
- Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin’s lymphomasBritish Journal of Cancer, 1999
- Bone marrow angiogenesis and progression in multiple myelomaBritish Journal of Haematology, 1994
- Putative tyrosine kinases expressed in K-562 human leukemia cells.Proceedings of the National Academy of Sciences, 1990